This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Welcome to the agenda for the 2013 MassDevice Big 100 West. All the pertinent event information logistics and updates will be hosted here.

If this is your first event, please take note that our program is rather unique. Our program is split into three portions.

First, we have educational sessions from 4:00-5:30. We call these our "Sparking the Conversation" sessions. These are generally panel discussions on hot button issues that med tech companies are facing, featuring executives and experts in each particular discipline. These sessions are concurrent, so you’ll have to pick one.

Second, we have a networking mixer with food and drinks so you can connect and re-connect with friends in the industry.

Finally, we have our main event featuring our CEO interviews. On December 10th we’ll hear from Dr. Robert Greenberg on the amazing rise of the "bionic eye," followed by a fascinating panel on the future of chronic diseases featuring C-level executives from ResMed, St. Jude Medical and Glooko. You can find information below on all those panels.

That’s all we have for now. Please make sure to reach out to the people you want to connect with and, as always, you can contact me with any questions.

View analytic

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Tuesday, December 10


Size Does Not Matter: Medtech Companies at Risk of Government Enforcement

Regardless of your company’s size, there are laws and regulations you cannot and should not ignore.  The risk of government scrutiny by the enforcement community is just too great.  Various government agencies - DOJ, OIG, FDA and SEC (to name a few) – have taken action and almost certainly will continue to take action against medical device companies for false claims violations, kickbacks, bribery and corruption, and off-label promotion.  The risk of financial and other penalties for companies and their executives can be significant and can put a growing company in serious jeopardy, financially and otherwise.


There are some basic and reasonable steps companies can and should take to prevent compliance missteps and limit their risk.  This session with Porzio Life Sciences and medtech industry leaders will help companies understand the risks and what they can do to address these risks so they can continue to effectively run and grow their businesses.


avatar for Michelle Axelrod

Michelle Axelrod

Principal, Porzio LifeSciences
Michelle Axelrod brings over 15 years of in-house experience at leading life sciences and related healthcare organizations to her role as Principal, Porzio, Bromberg & Newman and Vice President, Porzio Life Sciences. Michelle offers valuable insights and provides innovative ideas to support business goals while effectively protecting companies and reducing organizational risk. She counsels pharmaceutical, medical device and biotech clients on... Read More →


Diane Biagianti

VP, Chief Responsibility Officer, Edwards Lifesciences
Diane W. Biagianti is Vice President, Chief Responsibility Officer at Edwards Lifesciences LLC where she has responsibility for the company’s Ethics and Compliance program.  Prior to joining Edwards, Ms. Biagianti served as Divisional Vice President, Legal, for Abbott Medical Optics, Inc. from 2009 to 2011.  She formerly served as Senior Vice President, General Counsel and Assistant Secretary of Advanced Medical Optics, Inc... Read More →

Michael Crompton

VP, RA/QA, Chief Compliance Officer, Revision Optics, Inc.

Ed Crowe

Director, Porzio LifeSciences
avatar for Adam  Krauss

Adam Krauss

Associate General Counsel, Covidien

Tuesday December 10, 2013 4:00pm - 5:30pm
Hyatt Regency Irvine 17900 Jamboree Rd, Irvine, CA 92614


The Future of hospital purchasing - There has to be a better way
Rising SG&A costs, lack of insight into market performance with customers, and trying to gain access to new customers – all of these challenges can make it difficult to run an efficient business in today’s healthcare environment.

And while the majority of technology solutions have been focused on patient outcomes, hospitals and suppliers can’t neglect the fundamentals that put them in a position to be successful. Enter a new way of doing business with hospitals, one that leverages principles of a market to drive mutual beneficial contracting relationships. We will share how progressive healthcare organizations are adopting a new approach to address the concerns that are driving up costs in our industry.

Tuesday December 10, 2013 4:00pm - 5:30pm
Hyatt Regency Irvine 17900 Jamboree Rd, Irvine, CA 92614


“Hot topics: M&A, IP, Financing, and Products Liability Trends for MedTech Companies”
  • M&A trends from the perspective of both acquirer and seller
  • IP protection is key to a successful exit
  •  Financing best practices from early stage to exit
  • Products liability litigation - what every medtech company needs to know

avatar for J. Rick Taché

J. Rick Taché

Orange County Managing Shareholder; Co-Chair, Glob, Greenberg Traurig
J. Rick Taché is Managing Shareholder of the firm’s Orange County office and Co-Chair of the Global Patent Litigation Group. Rick is a registered patent attorney focusing his practice on intellectual property law, with an emphasis on patent, trademark, copyright, and trade secret litigation. His patent and trademark prosecution practice spans a variety of industries, including medical devices, aerospace, mechanical, software... Read More →


Eli Kammerman

VP, Business Development and Investor Relations, Masimo
avatar for Ginger Pigott

Ginger Pigott

Shareholder; Vice-Chair, Pharmaceutical, Medical D, Greenberg Traurig
Ginger Pigott focuses her practice on products liability litigation and commercial litigation. A particular focus of her practice lies in the defense of complex medical device and pharmaceutical products liability litigation, as well as counseling on pre-litigation issues that include document retention issues and best practices. She represents major corporations as part of national and regional counsel teams and on individual cases both in... Read More →

Larry Stofko

Executive Vice President, The Innovation Institute

Richard Yoon

Director of IP Strategy and Principal Patent Couns, Medtronic, Inc.| Diabetes

Tuesday December 10, 2013 4:00pm - 5:30pm
Hyatt Regency Irvine 17900 Jamboree Rd, Irvine, CA 92614


Networking reception
Connect and re-connect with friends from the medical device industry. Cocktails and food will be served.

Tuesday December 10, 2013 5:30pm - 6:30pm
Hyatt Regency Irvine 17900 Jamboree Rd, Irvine, CA 92614


Inside the bionic eye: A discussion with Second Sight Founder Robert Greenberg
avatar for Brian  Johnson

Brian Johnson

Publisher, Co-Founder, DeviceTalks, MassDevice, Medical Design & Outsourcing
Brian grew up in the medical devices industry -- as a child, he and his older brother used the surgical staplers his father sold for U.S. Surgical Corp. as toy guns. One episode involving about $10,000 worth of surgical staples earned him an early lesson about medical technology and its impact on people's lives. While pursuing his master’s degree in business and economics journalism from Boston University, Brian covered the 2004... Read More →

avatar for Dr. Robert Greenberg

Dr. Robert Greenberg

CEO, Second Sight Medical Products
Dr. Greenberg has worked in the field of retinal prosthetics for over twenty years. From 1991 to 1997, Dr. Greenberg conducted pre-clinical and clinical trials demonstrating the feasibility of retinal electrical stimulation to elicit visual perceptions. From 1997 to 1998, he served as a medical officer and lead reviewer for IDEs and 510(k)s at the Office of Device Evaluation at the U.S. Food and Drug Administration in the Neurological Devices... Read More →

Tuesday December 10, 2013 6:30pm - 7:15pm
Hyatt Regency Irvine 17900 Jamboree Rd, Irvine, CA 92614


Future of chronic diseases panel
The treatment of chronic diseases represents the singe largest business opportunity for the medical technology industry. However, new payment methods are changing the nature in which the industry will be reimbursed for innovations. In addition, new technologies are transforming the ways in which patients engage and interact with their treatment. In this panel we will look at three of the largest sectors of the chronic disease market to find out how executives in the diabetes, sleep apnea and cardiovascular arena view the opportunity and challenges of the next 10 years.

avatar for David Gollaher

David Gollaher

President and CEO, CHI
David Gollaher, President and Chief Executive Officer CHI-California Healthcare Institute co-founded CHI in 1993. Previously, he was a senior executive at Scripps Clinic and Research Foundation. Earlier in his career, he served on the faculties of Harvard University, University of California, San Diego, the Graduate School of Public Health at SDSU, and the Overseas School of Rome. He is an award-winning historian of science and medicine, and... Read More →

avatar for Rick Altinger

Rick Altinger

CEO, Glooko
Rick Altinger, CEO, Glooko has spent 20 years in the technology industry, concentrating on healthcare information technologies for the last 15 years. At Intuit, he launched the healthcare division’s provider services and drove the effort that resulted in Intuit acquiring Medfusion in May 2010. Medfusion, now the core of Intuit Health, is the leading supplier of patient-provider communication and patient portal services that improve... Read More →
avatar for Dr. Mark Carlson

Dr. Mark Carlson

Chief Medical Officer, St. Jude Medical
Mark Carlson, Chief Medical Officer, St. Jude Medical joined the company in 2006 as chief medical officer and senior vice president of clinical affairs for the Cardiac Rhythm Management division. He previously served as professor of medicine and associate vice president for government relations at Case Western Reserve University in Cleveland. He also served on the Medical Devices Dispute Resolution Panel for the U.S. Food and Drug Administration... Read More →
avatar for Michael Farrell

Michael Farrell

CEO, ResMed
Michael Farrell CEO, ResMed | Michael J. Farrell became chief executive officer in March 2013. Mr. Farrell has served as the Company’s president – Americas since May 2011. He was previously senior vice president, strategic business unit – sleep from July 2007 to May 2011, and before that role he was vice president, marketing for the Americas from June 2005 through July 2007, and vice president, business development. Before... Read More →

Tuesday December 10, 2013 7:15pm - 8:00pm
Hyatt Regency Irvine 17900 Jamboree Rd, Irvine, CA 92614